雷珠单抗与地塞米松植入物治疗视网膜中央静脉阻塞的比较：Ranidex研究 - Suppr

Suppr

超能文献

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study.

作者信息

Călugăru Dan, Călugăru Mihai

机构信息

Department of Ophthalmology, University of Medicine Cluj-Napoca/Romania, Cluj-Napoca, Romania.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):2073-2075. doi: 10.1007/s00417-017-3749-z. Epub 2017 Jul 25.

DOI:10.1007/s00417-017-3749-z

PMID:28744657

Abstract

摘要

相似文献

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study.雷珠单抗与地塞米松植入物治疗视网膜中央静脉阻塞的比较：Ranidex研究

Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):2073-2075. doi: 10.1007/s00417-017-3749-z. Epub 2017 Jul 25.

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study.

Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):2077-2078. doi: 10.1007/s00417-017-3750-6. Epub 2017 Jul 27.

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the RANIDEX study.雷珠单抗对比地塞米松植入物治疗视网膜中央静脉阻塞：RANIDEX研究

Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1899-1905. doi: 10.1007/s00417-017-3719-5. Epub 2017 Jun 15.

Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.美国雷珠单抗玻璃体内注射和地塞米松玻璃体内植入治疗视网膜静脉阻塞的治疗模式

Eye (Lond). 2017 Jul;31(7):1112-1113. doi: 10.1038/eye.2017.12. Epub 2017 Mar 17.

Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.对关于《美国雷珠单抗玻璃体内注射和地塞米松玻璃体内植入治疗视网膜静脉阻塞的治疗模式》评论的回复

Eye (Lond). 2017 Jul;31(7):1113-1114. doi: 10.1038/eye.2017.15. Epub 2017 Feb 24.

Comments on 'Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA'.关于“美国雷珠单抗玻璃体腔内注射和地塞米松玻璃体腔内植入治疗视网膜静脉阻塞的治疗模式”的评论

Eye (Lond). 2018 Feb;32(2):468-469. doi: 10.1038/eye.2017.178. Epub 2017 Aug 25.

Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.玻璃体内注射地塞米松植入物与玻璃体内注射雷珠单抗治疗中国人群视网膜静脉阻塞继发黄斑水肿的比较

Ophthalmic Res. 2017;58(1):8-14. doi: 10.1159/000458534. Epub 2017 Mar 24.

Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.玻璃体内注射地塞米松植入物治疗视网膜静脉阻塞继发的雷珠单抗耐药性黄斑水肿的疗效

Int Ophthalmol. 2017 Feb;37(1):47-53. doi: 10.1007/s10792-016-0226-3. Epub 2016 Apr 4.

Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion.低频雷珠单抗与地塞米松植入物治疗视网膜分支静脉阻塞继发黄斑水肿的比较

Clin Exp Optom. 2018 Jan;101(1):116-122. doi: 10.1111/cxo.12586. Epub 2017 Sep 18.

Eye (Lond). 2017 Apr;31(4):551-559. doi: 10.1038/eye.2016.269. Epub 2016 Dec 2.

引用本文的文献

Romanian ophthalmologists in the renowned ophthalmic journals worldwide.罗马尼亚眼科医生发表于全球知名眼科期刊上的文章。（原英文表述不太完整准确，推测完整意思应该是类似这样，若按照字面翻译是：罗马尼亚眼科医生在全球著名眼科期刊里）

Rom J Ophthalmol. 2018 Oct-Dec;62(4):260-269.

Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management.中心性/半侧视网膜静脉阻塞患者的高眼压症：累积患病率及管理

Int J Ophthalmol. 2018 Jul 18;11(7):1173-1178. doi: 10.18240/ijo.2018.07.16. eCollection 2018.

本文引用的文献

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the RANIDEX study.雷珠单抗对比地塞米松植入物治疗视网膜中央静脉阻塞：RANIDEX研究

Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1899-1905. doi: 10.1007/s00417-017-3719-5. Epub 2017 Jun 15.

Eye (Lond). 2017 Jul;31(7):1112-1113. doi: 10.1038/eye.2017.12. Epub 2017 Mar 17.

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion.基线脉络膜厚度作为视网膜中央静脉阻塞治疗结果的预测指标

Am J Ophthalmol. 2017 Apr;176:257-258. doi: 10.1016/j.ajo.2017.01.020. Epub 2017 Feb 9.

Dexamethasone intravitreal implant in retinal vein occlusion:real-life data from a prospective, multicenter clinical trial.地塞米松玻璃体内植入物治疗视网膜静脉阻塞：一项前瞻性多中心临床试验的真实世界数据

Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255(2):427-428. doi: 10.1007/s00417-016-3559-8. Epub 2016 Nov 30.

TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations.视网膜疾病中抗血管内皮生长因子（VEGF）药物的治疗与延长方案：文献综述与共识建议

Retina. 2015 Aug;35(8):1489-506. doi: 10.1097/IAE.0000000000000627.

Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study.玻璃体内注射贝伐单抗治疗急性中央/半侧中央视网膜静脉阻塞：一项前瞻性临床研究的三年结果

J Ocul Pharmacol Ther. 2015 Mar;31(2):78-86. doi: 10.1089/jop.2014.0037. Epub 2014 Oct 14.

Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.视网膜静脉阻塞所致黄斑水肿患者眼内注射地塞米松植入物后视力改善的起始时间和持续时间。

Retina. 2014 Sep;34(9):1743-9. doi: 10.1097/IAE.0000000000000167.

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.地塞米松玻璃体内植入物治疗与分支或中央视网膜静脉阻塞相关的黄斑水肿患者的 12 个月研究结果。

Ophthalmology. 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014. Epub 2011 Jul 20.

Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.雷珠单抗治疗视网膜中央静脉阻塞继发黄斑水肿的持续获益：一项 III 期研究的 12 个月结果。

Ophthalmology. 2011 Oct;118(10):2041-9. doi: 10.1016/j.ophtha.2011.02.038. Epub 2011 Jun 29.

Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).高清光谱域光学相干断层扫描（Spectralis）测量黄斑厚度的正常参考值。

Am J Ophthalmol. 2009 Aug;148(2):266-71. doi: 10.1016/j.ajo.2009.03.006. Epub 2009 May 9.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验